Canada Markets closed

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.3500-0.1300 (-5.24%)
At close: 4:00PM EDT
2.3700 +0.02 (0.85%)
After hours: 07:13PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 5290.86M
Enterprise Value 3349.63M
Trailing P/E N/A
Forward P/E 1-2.08
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)112.08
Price/Book (mrq)0.98
Enterprise Value/Revenue 3134.73
Enterprise Value/EBITDA 7-2.58

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.0800
52 Week Low 32.3200
50-Day Moving Average 32.7459
200-Day Moving Average 34.6261

Share Statistics

Avg Vol (3 month) 3744.42k
Avg Vol (10 day) 31.49M
Shares Outstanding 5123.77M
Implied Shares Outstanding 6N/A
Float 876.52M
% Held by Insiders 10.12%
% Held by Institutions 168.91%
Shares Short (Jun. 14, 2021) 44.83M
Short Ratio (Jun. 14, 2021) 411.47
Short % of Float (Jun. 14, 2021) 4N/A
Short % of Shares Outstanding (Jun. 14, 2021) 43.91%
Shares Short (prior month May 13, 2021) 44.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,307.63%

Management Effectiveness

Return on Assets (ttm)-23.14%
Return on Equity (ttm)-48.77%

Income Statement

Revenue (ttm)2.6M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.74M
EBITDA -135.72M
Net Income Avi to Common (ttm)-136.59M
Diluted EPS (ttm)-1.3200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)298.43M
Total Cash Per Share (mrq)2.41
Total Debt (mrq)53.96M
Total Debt/Equity (mrq)18.26
Current Ratio (mrq)6.77
Book Value Per Share (mrq)2.39

Cash Flow Statement

Operating Cash Flow (ttm)-115.61M
Levered Free Cash Flow (ttm)-63.13M